Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Ariad Pharmaceuticals (ARIA)

NASDAQ: Health Care

Get a 5-page Ratings Report on (ARIA) now
$16.67 0.20 | 1.21%
Today's Range: 16.40 - 16.85
ARIA Avg. Daily Volume: 3,022,300
05/17/13 - 4:00 PM ET
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: -12.2
  • Price Earnings Comparisons:
    ARIA Sector Avg. S&P 500
    -12.20 0.00 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    -17.65% -4.85% 294.96%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue -97.80 -0.93 -0.59
    Net Income 0.00 1.76 0.00
    EPS 0.00 0.56 0.00
  • Earnings for ARIA:
    EBITDA -205,060,000
    REVENUE 558,000
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $-0.41 $-0.44 $-1.64 $-1.31
Number of Analysts 10 9 12 11
High Estimate $-0.38 $-0.38 $-1.25 $-0.86
Low Estimate $-0.45 $-0.47 $-1.73 $-1.71
Prior Year $-0.31 $-0.32 $-1.34 $-1.64
Growth Rate (Year over Year) -30.65% -36.81% -22.76% 20.59%
(ARIA) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs